nach oben

Archives of Gynecology and Obstetrics

Erschienen in:

06.11.2019 | Gynecologic Oncology

Prognostic factors for and pattern of lymph-node involvement in patients with operable cervical cancer

verfasst von: P. Widschwendter, W. Janni, C. Scholz, A. De Gregorio, N. De Gregorio, T W P Friedl

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 6/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Lymph node metastases significantly worsen the prognosis in cervical carcinoma. Risk factors—pathological and patient related—could select patients at high risk for lymph node involvement.

Methods

This retrospective analysis was performed by analyzing data from patients with cervical carcinoma treated between 2000 and 2017 at the Department of Obstetrics and Gynecology of the University Hospital Ulm.

Results

In total, 261 patients with cervical carcinoma (International Federation of Gynecology and Obstetrics (FIGO) stage IA–IIB) and lymphadenectomy with at least 10 removed lymph nodes were available for analysis. Overall, 86 (33.0%) patients had lymph node metastases; 73 patients had pelvic lymph node metastases only and 13 patients had both pelvic and paraaortic lymph node metastases. Lymph node metastases were found most often in the region of the external iliac artery and obturator fossa, with 57.0% and 54.7% of all 86 node-positive patients, respectively. Univariable analyses showed that presence of lymph node metastases was significantly associated with both preoperative FIGO stage (p = 0.001) and final pathological tumor stage (p < 0.001), status of resection margin (p = 0.002), lymphovascular space invasion (LVSI), (p < 0.001) and vascular space invasion, (p < 0.001). In a multivariable logistic regression model with presence of lymph node metastases (yes/no) as binary response variable, only LVSI (p < 0.001) and body mass index (BMI), (p = 0.035) remained as significant independent predictors of lymph node involvement. Subgroup analyses showed that LVSI was a significant predictive factor for lymph node involvement in patients with a preoperatively assessed FIGO stage < IIB (p < 0.001), but not for patients with a preoperatively assessed FIGO stage ≥ IIB (p = 0.122).

Conclusions

The risk factor LVSI should play an important role in deciding whether an individualized therapy concept is based on escalating or deescalating treatment. In future, the sentinel concept could reduce morbidity and at the same time provide an important prognostic assessment for a subset of cervical cancer patients.

Piver MS, Chung WS (1975) Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma. Obstet Gynecol 46:507–510PubMed

Takekuma M, Kasamatsu Y, Kado N, Kuji S, Tanaka A, Takahashi N, Abe M, Hirashima Y (2017) The issues regarding postoperative adjuvant therapy and prognostic risk factors for patients with stage I–II cervical cancer: a review. J Obstet Gynaecol Res 43:617–626. https://doi.org/10.1111/jog.13282 CrossRefPubMed

Bhatla N, Berek JS, Cuello Fredes M, Denny LA, Grenman S, Karunaratne K, Kehoe ST, Konishi I, Olawaiye AB, Prat J, Sankaranarayanan R, Brierley J, Mutch D, Querleu D, Cibula D, Quinn M, Botha H, Sigurd L, Rice L, Ryu H-S, Ngan H, Mäenpää J, Andrijono A, Purwoto G, Maheshwari A, Bafna UD, Plante M, Natarajan J (2019) Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynecol Obstet 145:129–135. https://doi.org/10.1002/ijgo.12749 CrossRef

Tsunoda AT, Marnitz S, Soares Nunes J, de Cunha Andrade CEM, Scapulatempo Neto C, Blohmer J-U, Herrmann J, Kerr LM, Martus P, Schneider A, Favero G, Köhler C (2017) Incidence of histologically proven pelvic and para-aortic lymph node metastases and rate of upstaging in patients with locally advanced cervical cancer: results of a prospective randomized trial. Oncology 92:213–220. https://doi.org/10.1159/000453666 CrossRefPubMed

Köhler C, Mustea A, Marnitz S, Schneider A, Chiantera V, Ulrich U, Scharf J-P, Martus P, Vieira MA, Tsunoda A (2015) Perioperative morbidity and rate of upstaging after laparoscopic staging for patients with locally advanced cervical cancer: results of a prospective randomized trial. Am J Obstet Gynecol 213:503.e1–503.e7. https://doi.org/10.1016/j.ajog.2015.05.026 CrossRef

Ferrandina G, Margariti PA, Smaniotto D, Petrillo M, Salerno MG, Fagotti A, Macchia G, Morganti AG, Cellini N, Scambia G (2010) Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery. Gynecol Oncol 119:404–410. https://doi.org/10.1016/j.ygyno.2010.08.004 CrossRefPubMed

Maggioni A, Benedetti Panici P, Dell’Anna T, Landoni F, Lissoni A, Pellegrino A, Rossi R, Chiari S, Campagnutta E, Greggi S, Angioli R, Manci N, Calcagno M, Scambia G, Fossati R, Floriani I, Torri V, Grassi R, Mangioni C (2006) Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer 95:699–704. https://doi.org/10.1038/sj.bjc.6603323 CrossRefPubMedPubMedCentral

Marth C, Landoni F, Mahner S, McCormack M, Gonzalez-Martin A, Colombo N (2017) ESMO Guidelines Committee, cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol Off J Eur Soc Med Oncol 28:iv72–iv83. https://doi.org/10.1093/annonc/mdx220 CrossRef

Horn L-C, Beckmann MW, Follmann M, Koch MC, Mallmann P, Marnitz S, Schmidt D (2015) German Cancer Society (DKG), S3-Leitlinie Diagnostik und Therapie des Zervixkarzinoms. Pathologe 36:585–593. https://doi.org/10.1007/s00292-015-0114-z CrossRefPubMed

10.

Zigras T, Lennox G, Willows K, Covens A (2017) Early cervical cancer: current dilemmas of staging and surgery. Curr Oncol Rep 19:51. https://doi.org/10.1007/s11912-017-0614-5 CrossRefPubMed

11.

Rotman M, Sedlis A, Piedmonte MR, Bundy B, Lentz SS, Muderspach LI, Zaino RJ (2006) A phase III randomized trial of postoperative pelvic irradiation in stage IB cervical carcinoma with poor prognostic features: follow-up of a gynecologic oncology group study. Int J Radiat Oncol 65:169–176. https://doi.org/10.1016/j.ijrobp.2005.10.019 CrossRef

12.

Sedlis A, Bundy BN, Rotman MZ, Lentz SS, Muderspach LI, Zaino RJ (1999) A randomized trial of pelvic radiation therapy versus no further therapy in selected patients with stage IB carcinoma of the cervix after radical hysterectomy and pelvic lymphadenectomy: a Gynecologic Oncology Group Study. Gynecol Oncol 73:177–183. https://doi.org/10.1006/gyno.1999.5387 CrossRefPubMed

13.

Morice P, Piovesan P, Rey A, Atallah D, Haie-Meder C, Pautier P, Sideris L, Pomel C, Duvillard P, Castaigne D (2003) Prognostic value of lymphovascular space invasion determined with hematoxylin-eosin staining in early stage cervical carcinoma: results of a multivariate analysis. Ann Oncol 14:1511–1517. https://doi.org/10.1093/annonc/mdg412 CrossRefPubMed

14.

Monk BJ, Wang J, Im S, Stock RJ, Peters WA, Liu PY, Barrett RJ, Berek JS, Souhami L, Grigsby PW, Gordon W, Alberts DS (2005) Gynecologic oncology group, southwest oncology group, radiation therapy oncology group, rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical–pathologic analysis of a gynecologic oncology group/southwest oncology group/radiation therapy oncology group trial. Gynecol Oncol 96:721–728. https://doi.org/10.1016/j.ygyno.2004.11.007 CrossRefPubMed

15.

Uno T, Ito H, Isobe K, Kaneyasu Y, Tanaka N, Mitsuhashi A, Suzuka K, Yamazawa K, Shigematsu N, Itami J (2005) Postoperative pelvic radiotherapy for cervical cancer patients with positive parametrial invasion. Gynecol Oncol 96:335–340. https://doi.org/10.1016/j.ygyno.2004.09.061 CrossRefPubMed

16.

Höckel M, Horn L-C, Manthey N, Braumann U-D, Wolf U, Teichmann G, Frauenschläger K, Dornhöfer N, Einenkel J (2009) Resection of the embryologically defined uterovaginal (Müllerian) compartment and pelvic control in patients with cervical cancer: a prospective analysis. Lancet Oncol 10:683–692. https://doi.org/10.1016/S1470-2045(09)70100-7 CrossRefPubMed

17.

Macdonald OK, Chen J, Dodson M, Lee CM, Gaffney DK (2009) Prognostic significance of histology and positive lymph node involvement following radical hysterectomy in carcinoma of the cervix. Am J Clin Oncol 32:411–416. https://doi.org/10.1097/COC.0b013e31819142dc CrossRefPubMed

18.

Fleming ND, Frumovitz M, Schmeler KM, dos Reis R, Munsell MF, Eifel PJ, Soliman PT, Nick AM, Westin SN, Ramirez PT (2015) Significance of lymph node ratio in defining risk category in node-positive early stage cervical cancer. Gynecol Oncol 136:48–53. https://doi.org/10.1016/j.ygyno.2014.11.010 CrossRefPubMed

19.

Chen Y, Zhang L, Tian J, Fu X, Ren X, Hao Q (2013) Significance of the absolute number and ratio of metastatic lymph nodes in predicting postoperative survival for the international federation of gynecology and obstetrics stage IA2 to IIA cervical cancer. Int J Gynecol Cancer 23:157–163. https://doi.org/10.1097/IGC.0b013e3182778bcf CrossRefPubMed

20.

Kwon J, Eom K-Y, Kim YS, Park W, Chun M, Lee J, Kim YB, Yoon WS, Kim JH, Choi JH, Chang SK, Jeong BK, Lee SH, Cha J (2018) The prognostic impact of the number of metastatic lymph nodes and a new prognostic scoring system for recurrence in early-stage cervical cancer with high risk factors: a multicenter cohort study (KROG 15-04). Cancer Res Treat 50:964–974. https://doi.org/10.4143/crt.2017.346 CrossRefPubMed

21.

Matsuo K, Grubbs BH, Mikami M (2018) Quality and quantity metrics of pelvic lymph node metastasis and risk of para-aortic lymph node metastasis in stage IB–IIB cervical cancer. J Gynecol Oncol 29:e10. https://doi.org/10.3802/jgo.2018.29.e10 CrossRefPubMed

22.

Cibula D, Pötter R, Planchamp F, Avall-Lundqvist E, Fischerova D, Haie Meder C, Köhler C, Landoni F, Lax S, Lindegaard JC, Mahantshetty U, Mathevet P, McCluggage WG, McCormack M, Naik R, Nout R, Pignata S, Ponce J, Querleu D, Raspagliesi F, Rodolakis A, Tamussino K, Wimberger P, Raspollini MR (2018) The European Society of Gynaecological Oncology/European Society for Radiotherapy and Oncology/European Society of Pathology Guidelines for the management of patients with cervical cancer. Int J Gynecol Cancer 28:641–655. https://doi.org/10.1097/igc.0000000000001216 CrossRefPubMed

23.

Grigsby PW, Heydon K, Mutch DG, Kim RY, Eifel P (2001) Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys 51:982–987CrossRef

24.

Mangler M, Zech N, Schneider A, Köhler C, Marnitz S (2013) Aspects of therapy for cervical cancer in Germany 2012: results from a survey of German Gynaecological Hospitals. Geburtshilfe Frauenheilkd 73:227–238. https://doi.org/10.1055/s-0032-1328302 CrossRefPubMedPubMedCentral

25.

Minig L, Patrono MG, Romero N, Rodríguez Moreno JF, Garcia-Donas J (2014) Different strategies of treatment for uterine cervical carcinoma stage IB2–IIB. World J Clin Oncol 5:86. https://doi.org/10.5306/wjco.v5.i2.86 CrossRefPubMedPubMedCentral

26.

Li X, Yin Y, Sheng X, Han X, Sun L, Lu C, Wang X (2015) Distribution pattern of lymph node metastases and its implication in individualized radiotherapeutic clinical target volume delineation of regional lymph nodes in patients with stage IA to IIA cervical cancer. Radiat Oncol 10:40. https://doi.org/10.1186/s13014-015-0352-5 CrossRefPubMedPubMedCentral

27.

Sakuragi N, Satoh C, Takeda N, Hareyama H, Takeda M, Yamamoto R, Fujimoto T, Oikawa M, Fujino T, Fujimoto S (1999) Incidence and distribution pattern of pelvic and paraaortic lymph node metastasis in patients with stages IB, IIA, and IIB cervical carcinoma treated with radical hysterectomy. Cancer 85:1547–1554CrossRef

28.

Marnitz S, Köhler C, Bongardt S, Braig U, Hertel H, Schneider A (2006) German Association of Gynecologic Oncologists (AGO), topographic distribution of sentinel lymph nodes in patients with cervical cancer. Gynecol Oncol 103:35–44. https://doi.org/10.1016/j.ygyno.2006.01.061 CrossRefPubMed

29.

Lee J-M, Lee K-B, Lee S-K, Park C-Y (2007) Pattern of lymph node metastasis and the optimal extent of pelvic lymphadenectomy in FIGO stage IB cervical cancer. J Obstet Gynaecol Res 33:288–293. https://doi.org/10.1111/j.1447-0756.2007.00526.x CrossRefPubMed

30.

Takeshita S, Todo Y, Okamoto K, Sudo S, Yamashiro K, Kato H (2016) Incidence of metastasis in circumflex iliac nodes distal to the external iliac nodes in cervical cancer. J Gynecol Oncol 27:e42. https://doi.org/10.3802/jgo.2016.27.e42 CrossRefPubMedPubMedCentral

31.

Takeda N, Sakuragi N, Takeda M, Okamoto K, Kuwabara M, Negishi H, Oikawa M, Yamamoto R, Yamada H, Fujimoto S (2002) Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand 81:1144–1151CrossRef

32.

Delgado G, Bundy B, Zaino R, Sevin BU, Creasman WT, Major F (1990) Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol Oncol 38:352–357CrossRef

33.

Ryu S-Y, Park S-I, Nam B-H, Cho C-K, Kim K, Kim B-J, Kim M-H, Choi S-C, Lee E-D, Lee K-H (2011) Is adjuvant chemoradiotherapy overtreatment in cervical cancer patients with intermediate risk factors? Int J Radiat Oncol 79:794–799. https://doi.org/10.1016/j.ijrobp.2009.11.019 CrossRef

34.

Smith B, McCann GA, Phillips G, Backes FJ, O’Malley DM, Cohn DE, Fowler JM, Copeland LJ, Salani R (2017) Less radical surgery for early-stage cervical cancer: can conization specimens help identify patients at low risk for parametrial involvement? Gynecol Oncol 144:290–293. https://doi.org/10.1016/j.ygyno.2016.11.029 CrossRefPubMed

35.

Bidus MA, Caffrey AS, You WB, Amezcua CA, Chernofsky MR, Barner R, Seidman J, Rose GS (2008) Cervical biopsy and excision procedure specimens lack sufficient predictive value for lymph-vascular space invasion seen at hysterectomy for cervical cancer. Am J Obstet Gynecol 199:151.e1–151.e4. https://doi.org/10.1016/j.ajog.2008.02.017 CrossRef

36.

Cibula D, McCluggage WG (2019) Sentinel lymph node (SLN) concept in cervical cancer: current limitations and unanswered questions. Gynecol Oncol 152:202–207. https://doi.org/10.1016/j.ygyno.2018.10.007 CrossRefPubMed

Titel: Prognostic factors for and pattern of lymph-node involvement in patients with operable cervical cancer
verfasst von: P. Widschwendter
W. Janni
C. Scholz
A. De Gregorio
N. De Gregorio
T W P Friedl
Publikationsdatum: 06.11.2019
Verlag: Springer Berlin Heidelberg
Erschienen in: Archives of Gynecology and Obstetrics / Ausgabe 6/2019
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI: https://doi.org/10.1007/s00404-019-05341-3

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Ambulantisierung: Erste Erfahrungen mit dem Hybrid-DRG

02.05.2024 DCK 2024 Kongressbericht

Die Hybrid-DRG-Verordnung soll dazu führen, dass mehr chirurgische Eingriffe ambulant durchgeführt werden, wie es in anderen Ländern schon länger üblich ist. Die gleiche Vergütung im ambulanten und stationären Sektor hatten Niedergelassene schon lange gefordert. Aber die Umsetzung bereitet ihnen doch Kopfzerbrechen.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Harninkontinenz: Netz-Op. erfordert über lange Zeit intensive Nachsorge

30.04.2024 Harninkontinenz Nachrichten

Frauen mit Belastungsinkontinenz oder Organprolaps sind nach einer Netz-Operation keineswegs beschwerdefrei. Vielmehr scheint die Krankheitslast weiterhin hoch zu sein, sogar höher als von harninkontinenten Frauen, die sich nicht haben operieren lassen.

Welche Übungen helfen gegen Diastase recti abdominis?

30.04.2024 Schwangerenvorsorge Nachrichten

Die Autorinnen und Autoren einer aktuellen Studie aus Griechenland sind sich einig, dass Bewegungstherapie, einschließlich Übungen zur Stärkung der Bauchmuskulatur und zur Stabilisierung des Rumpfes, eine Diastase recti abdominis postpartum wirksam reduzieren kann. Doch vieles ist noch nicht eindeutig belegt.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 6/2019

Analysis of big data for prediction of provider-initiated preterm birth and spontaneous premature deliveries and ranking the predictive features

Intramural ectopic pregnancy following pelvic adhesion: case report and literature review

Response to “Letter to the Editor” by Federico Prefumo

Effect of embryo selection based morphokinetics on IVF/ICSI outcomes: evidence from a systematic review and meta-analysis of randomized controlled trials